# Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852

> **NCT03381703** · PHASE1 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 10 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** YH12852
- **DRUG:** 14C-labeled YH12852

## Key facts

- **NCT ID:** NCT03381703
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-16
- **Primary completion:** 2017-03-29
- **Final completion:** 2017-03-29
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03381703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03381703, "Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03381703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*